carbamates has been researched along with rasagiline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, T; Bar-Am, O; Weinstock, M; Yogev-Falach, M; Youdim, MB | 1 |
| Amit, T; Bar-Am, O; Sagi, Y; Yogev-Falach, M; Youdim, MB | 1 |
| Ashani, Y; Groner, E; Herzig, Y; Schorer-Apelbaum, D; Sterling, J; Weinstock, M | 1 |
| Alonso, N; Caamaño, O; D S Cordeiro, MN; García-Mera, X; González-Díaz, H; Luan, F; Romero-Duran, FJ; Yañez, M | 1 |
| Alonso, N; Caamaño, O; García-Mera, X; González-Díaz, H; Prado-Prado, FJ; Romero Durán, FJ; Yañez, M | 1 |
5 other study(ies) available for carbamates and rasagiline
| Article | Year |
|---|---|
Amyloid processing and signal transduction properties of antiparkinson-antialzheimer neuroprotective drugs rasagiline and TV3326.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Carbamates; Cell Line; Enzyme Activation; Enzyme Inhibitors; Humans; Indans; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Parkinson Disease; Rats; Signal Transduction | 2003 |
Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo.
Topics: Amyloid beta-Protein Precursor; Animals; Antiparkinson Agents; Carbamates; Glucosidases; Hippocampus; Indans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Myristoylated Alanine-Rich C Kinase Substrate; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein Processing, Post-Translational; Receptors for Activated C Kinase; Receptors, Cell Surface | 2004 |
The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Carbamates; Humans; Indans; Inhibition, Psychological; Inhibitory Concentration 50; Kinetics; Monoamine Oxidase Inhibitors; Phenylcarbamates; Rivastigmine; Selegiline | 2007 |
Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates.
Topics: Animals; Carbamates; Clinical Trials as Topic; Computer Simulation; Drug Delivery Systems; Glutamic Acid; High-Throughput Screening Assays; Humans; Indans; Neuroprotective Agents; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sensitivity and Specificity; Spectrum Analysis; Stochastic Processes | 2013 |
Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates.
Topics: Algorithms; Animals; Carbamates; Cell Survival; Cells, Cultured; Cerebral Cortex; Databases, Pharmaceutical; Drug Evaluation, Preclinical; Entropy; Glutamic Acid; Indans; Models, Chemical; Molecular Structure; Neuroprotective Agents; Quantitative Structure-Activity Relationship; Rats | 2014 |